Coronavirus disease-2019 (COVID-19) is caused by severe acute respiratory syndrome-coronavirus-2, which primarily affects the respiratory tract. After emerging in China in late 2019, it was declared a pandemic by the World Health Organization (WHO) on March 11, 2020. 1 As of March 13, 2023, 760,360,956 cases have been reported globally, and 17,042,722 cases in Türkiye were reported until November 27, 2022. 2,3 Reverse transcription-polymerase chain reaction (RT-PCR) is considered the standard diagnostic test for COVID-19 infection. 4 Furthermore, chest computed tomography (CT) is used to assess the severity of lung involvement in the COVID-19 patients with a positive RT-PCR result. However, chest CT can also help in diagnosing and guidance on the treatment for COVID-19 patients with a negative RT-PCR report. 5 Thus, CT scans are increasingly used by emergency departments and outpatient clinics for diagnostic purposes. Moreover, the number of incidental findings has increased due to the enhanced utilization of CT scans during the COVID-19 pandemic. 6 Lung cancer is one of the most frequently diagnosed cancers and a leading cause of cancer-related deaths worldwide. The majority of lung cancer patients have locally advanced or metastatic